{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:08:41Z","timestamp":1789247321430,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.adro.2026.102083","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:26:50Z","timestamp":1789122410000},"page":"102083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of Life and Toxicities Following Whole-Palm Versus Involved-Field Radiation Therapy for Dupuytren\u2019s Disease: A Substudy From a Randomized Trial"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1664-2254","authenticated-orcid":false,"given":"Renee","family":"Duvenage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad M.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.N.","family":"Werker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Rozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel J.H.M.","family":"Steenbakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreelakshmi","family":"Anoora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Sandoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Sappiatzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schlect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hunter-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102083_bib0001","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2106\/00004623-200701000-00026","article-title":"Dupuytren disease: Anatomy, pathology, presentation, and treatment","volume":"89","author":"Rayan","year":"2007","journal-title":"J Bone Joint Surg Am."},{"key":"10.1016\/j.adro.2026.102083_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PRS.0b013e3182958a33","article-title":"Prevalence of Dupuytren disease in the Netherlands","volume":"132","author":"Lanting","year":"2013","journal-title":"Plast Reconstr Surg."},{"key":"10.1016\/j.adro.2026.102083_bib0003","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.hcl.2018.03.002","article-title":"Risk factors, disease associations, and Dupuytren diathesis","volume":"34","author":"Hindocha","year":"2018","journal-title":"Hand Clin."},{"key":"10.1016\/j.adro.2026.102083_bib0004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PRS.0000000000007146","article-title":"Nongenetic factors associated with Dupuytren\u2019s disease: A systematic review","volume":"146","author":"Alser","year":"2020","journal-title":"Plast Reconstr Surg."},{"key":"10.1016\/j.adro.2026.102083_bib0005","first-page":"595","article-title":"Radiation therapy for nonmalignant diseases: An ASTRO-ESTRO-DEGRO-RANZCR framework","volume":"124","author":"Martin","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.adro.2026.102083_bib0006","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00066-010-2063-z","article-title":"Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years","volume":"186","author":"Betz","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2026.102083_bib0007","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0360-3016(00)00745-8","article-title":"Radiotherapy optimisation in early-stage Dupuytren\u2019s contracture: First results of a randomised clinical study","volume":"49","author":"Seegenschmiedt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.adro.2026.102083_bib0008","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1753193417695996","article-title":"Radiotherapy in Dupuytren\u2019s disease: A systematic review of the evidence","volume":"42","author":"Kadhum","year":"2017","journal-title":"J Hand Surg Eur Vol."},{"key":"10.1016\/j.adro.2026.102083_bib0009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-015-0818-2","article-title":"DEGRO guidelines for the radiotherapy of non-malignant disorders: Part III: Hyperproliferative disorders","volume":"191","author":"Seegenschmiedt","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2026.102083_bib0010","unstructured":"The Royal College of Radiologists. Recommendations for using radiotherapy for benign disease in the UK. Accessed January 25, 2026. https:\/\/www.rcr.ac.uk\/our-services\/all-our-publications\/clinical-oncology-publications\/recommendations-for-using-radiotherapy-for-benign-disease-in-the-uk\/."},{"key":"10.1016\/j.adro.2026.102083_bib0011","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ijrobp.2025.09.037","volume":"124","author":"Martin","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.adro.2026.102083_bib0012","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L","article-title":"Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder and hand) [corrected]. The upper extremity collaborative group (UECG)","volume":"29","author":"Hudak","year":"1996","journal-title":"Am J Ind Med."},{"key":"10.1016\/j.adro.2026.102083_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-7-44","article-title":"The shortened Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH): Validity and reliability","volume":"7","author":"Gummesson","year":"2006","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.adro.2026.102083_bib0014","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/acr.20564","article-title":"Unit\u00e9 Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren\u2019s disease-specific disability","volume":"63","author":"Beaudreuil","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.adro.2026.102083_bib0015","first-page":"515","article-title":"Development and validation of a patient-reported outcome measure for Dupuytren\u2019s disease: The URAM scale","volume":"36","author":"Beaudreuil","year":"2011","journal-title":"J Hand Surg Eur Vol."},{"key":"10.1016\/j.adro.2026.102083_bib0016","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 4.03. National Institutes of Health; 2010. Accessed January 25, 2026. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/trial-development"},{"key":"10.1016\/j.adro.2026.102083_bib0017","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jhsa.2012.06.032","article-title":"Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: The importance of clear definitions","volume":"37","author":"Werker","year":"2012","journal-title":"J Hand Surg Am."},{"key":"10.1016\/j.adro.2026.102083_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1302\/2058-5241.4.180021","article-title":"Dupuytren\u2019s disease: Where do we stand?","volume":"4","author":"Grazina","year":"2019","journal-title":"EFORT Open Rev."},{"key":"10.1016\/j.adro.2026.102083_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109718","article-title":"Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial","volume":"185","author":"de Haan","year":"2023","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.adro.2026.102083_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/17531934221131373","article-title":"Treatments for early-stage Dupuytren\u2019s disease: An evidence-based approach","volume":"48","author":"Nanchahal","year":"2023","journal-title":"J Hand Surg Eur Vol."}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:52:17Z","timestamp":1789246337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2452109426000904"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102083","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life and Toxicities Following Whole-Palm Versus Involved-Field Radiation Therapy for Dupuytren\u2019s Disease: A Substudy From a Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102083"}}